NO20042666L - Kombinasjon av cytokrom P450-avhengige proteaseinhibitorer - Google Patents

Kombinasjon av cytokrom P450-avhengige proteaseinhibitorer

Info

Publication number: NO20042666L
Authority: NO; Norway
Prior art keywords: cytochrome; combination; protease inhibitors; dependent protease; dependent
Prior art date: 2001-12-12

Application number

NO20042666A

Other languages

English (en)

Norwegian (no)

Inventor

Ronald Van Der Geest

Paul Stoffels

Cornelis Groen

Dirk Edward Desire Jochmans

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-12

Filing date

2004-06-24

Publication date

2004-09-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8181408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20042666(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-24 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2004-09-09 Publication of NO20042666L publication Critical patent/NO20042666L/no

Links

102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 title 1
108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 title 1
230000001419 dependent effect Effects 0.000 title 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
239000000137 peptide hydrolase inhibitor Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Ultra Sonic Daignosis Equipment (AREA)

NO20042666A 2001-12-12 2004-06-24 Kombinasjon av cytokrom P450-avhengige proteaseinhibitorer NO20042666L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01204841		2001-12-12
PCT/EP2002/014277 WO2003049746A2 (en)	2001-12-12	2002-12-12	Combination of cytochome p450 dependent protease inhibitors

Publications (1)

Publication Number	Publication Date
NO20042666L true NO20042666L (no)	2004-09-09

Family

ID=8181408

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042666A NO20042666L (no)	2001-12-12	2004-06-24	Kombinasjon av cytokrom P450-avhengige proteaseinhibitorer

Country Status (27)

Country	Link
US (1)	US20050119338A1 (pt)
EP (1)	EP1458447B1 (pt)
JP (1)	JP2005511723A (pt)
KR (1)	KR100974921B1 (pt)
CN (1)	CN100335060C (pt)
AR (1)	AR037797A1 (pt)
AT (1)	ATE442189T1 (pt)
AU (1)	AU2002358713B2 (pt)
BR (1)	BR0215043A (pt)
CA (1)	CA2469343C (pt)
CY (1)	CY1110604T1 (pt)
DE (1)	DE60233677D1 (pt)
DK (1)	DK1458447T3 (pt)
ES (1)	ES2333206T3 (pt)
HR (1)	HRP20040619A2 (pt)
HU (1)	HUP0402644A3 (pt)
IL (1)	IL162353A0 (pt)
MX (1)	MXPA04005755A (pt)
NO (1)	NO20042666L (pt)
NZ (1)	NZ533826A (pt)
PL (1)	PL373072A1 (pt)
PT (1)	PT1458447E (pt)
RU (1)	RU2329050C2 (pt)
SI (1)	SI1458447T1 (pt)
TW (1)	TWI286476B (pt)
WO (1)	WO2003049746A2 (pt)
ZA (1)	ZA200404633B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0414916A (pt) *	2003-09-30	2006-11-07	Tibotec Pharm Ltd	métodos para a preparação de compostos de sulfonamida de benzoxazol e intermediários dos mesmos
US20070104740A1 (en) *	2003-12-23	2007-05-10	Voorspoels Jody Firmin M	Self-microemulsifying drug delivery systems of a hiv protease inhibitor
US7378441B2 (en) *	2004-05-07	2008-05-27	Sequoia Pharmaceuticals, Inc.	Resistance-repellent retroviral protease inhibitors
WO2006005720A1 (en) *	2004-07-08	2006-01-19	Tibotec Pharmaceuticals Ltd.	Combination of anti-hiv reverse transcriptase and protease inhibitors
DK1856125T3 (da)	2005-02-25	2009-12-07	Tibotec Pharm Ltd	Syntese af proteasehæmmerforstadie
EP2842559A3 (en) *	2005-04-08	2015-03-18	Chimerix, Inc.	Compounds, compositions and methods for the treatment of viral infections and other medical disorders
AR053845A1 (es)	2005-04-15	2007-05-23	Tibotec Pharm Ltd	5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
AR057182A1 (es)	2005-11-28	2007-11-21	Tibotec Pharm Ltd	Compuestos de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih
TWI432438B (zh)	2005-11-28	2014-04-01	Tibotec Pharm Ltd	作為ｈｉｖ蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物及衍生物
EP1976517A1 (en) *	2005-12-30	2008-10-08	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
JO2841B1 (en) *	2006-06-23	2014-09-15	تيبوتيك فارماسيوتيكالز ليمتد	2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
AU2007285759B2 (en)	2006-08-18	2013-11-21	Sequoia Pharmaceuticals, Inc.	Compositions and methods for inhibiting cytochrome P450
EP2139883A4 (en) *	2007-03-23	2011-06-22	Univ Massachusetts	HIV-1 protease inhibitor
UA103013C2 (uk)	2007-12-06	2013-09-10	Тиботек Фармасьютикелз	Амідні сполуки як активатори противірусних препаратів
GT200800303A (es) *	2007-12-24	2009-09-18		Combinacion anti-retroviral
ES2572631T3 (es)	2008-01-25	2016-06-01	Chimerix, Inc.	Métodos de tratamiento de infecciones virales
EP2346842A1 (en)	2008-10-07	2011-07-27	Tibotec Pharmaceuticals	New amide compounds as boosters of antivirals
EP2429290B1 (en) *	2009-05-11	2014-01-01	Purdue Research Foundation	Compounds and methods for treating aids and hiv infections
JO3090B1 (ar) *	2009-12-11	2017-03-15	Janssen Sciences Ireland Uc	5- امينو-4- هيدروكسي-بنتويل اميدات
US9006218B2 (en)	2010-02-12	2015-04-14	Chimerix Inc.	Nucleoside phosphonate salts
CA2797601A1 (en)	2010-04-26	2011-11-10	Chimerix, Inc.	Methods of treating retroviral infections and related dosage regimes
EP2576544A4 (en) *	2010-06-01	2013-09-11	Angion Biomedica Corp	INHIBITORS OF CYTOCHROMES P450 AND USES THEREOF
EP2729130B1 (en)	2011-07-07	2017-09-06	Janssen Sciences Ireland UC	Darunavir combination formulations
SI2729128T1 (sl)	2011-07-07	2016-11-30	Janssen Sciences Ireland Uc	Formulacije darunavirja

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995010281A1 (en) *	1993-10-13	1995-04-20	Merck & Co., Inc.	Combination therapy for hiv infection
US6037157A (en) *	1995-06-29	2000-03-14	Abbott Laboratories	Method for improving pharmacokinetics
CA2262900A1 (en) *	1996-08-05	1998-02-12	Molecumetics Ltd.	Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
US6180634B1 (en) *	1997-11-13	2001-01-30	Merck & Co., Inc.	Combination therapy for the treatment of AIDS
US6436989B1 (en) *	1997-12-24	2002-08-20	Vertex Pharmaceuticals, Incorporated	Prodrugs of aspartyl protease inhibitors
CA2872424C (en) *	1998-06-23	2017-03-07	The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Bisfuran derivatives useful in preventing the emergence of multidrug resistant hiv strains and treatment of hiv
AU4828199A (en) *	1998-06-23	2000-01-10	Board Of Trustees Of The University Of Illinois, The	Multi-drug resistant retroviral protease inhibitors and associated methods
MY121765A (en) *	1998-07-20	2006-02-28	Abbott Lab	Polymorph of ritonavir
TNSN00027A1 (fr) *	1999-02-12	2005-11-10	Vertex Pharma	Inhibiteurs de l'aspartyle protease
JP4814427B2 (ja) *	1999-02-12	2011-11-16	バーテックスファーマシューティカルズインコーポレイテッド	アスパルチルプロテアーゼのインヒビター

2002
- 2002-12-11 TW TW091135882A patent/TWI286476B/zh not_active IP Right Cessation
- 2002-12-11 AR ARP020104805A patent/AR037797A1/es unknown
- 2002-12-12 KR KR1020047008830A patent/KR100974921B1/ko not_active Ceased
- 2002-12-12 IL IL16235302A patent/IL162353A0/xx unknown
- 2002-12-12 AU AU2002358713A patent/AU2002358713B2/en not_active Revoked
- 2002-12-12 EP EP02793018A patent/EP1458447B1/en not_active Revoked
- 2002-12-12 DE DE60233677T patent/DE60233677D1/de not_active Expired - Lifetime
- 2002-12-12 PT PT02793018T patent/PT1458447E/pt unknown
- 2002-12-12 NZ NZ533826A patent/NZ533826A/en not_active IP Right Cessation
- 2002-12-12 WO PCT/EP2002/014277 patent/WO2003049746A2/en not_active Ceased
- 2002-12-12 CA CA002469343A patent/CA2469343C/en not_active Expired - Fee Related
- 2002-12-12 AT AT02793018T patent/ATE442189T1/de not_active IP Right Cessation
- 2002-12-12 HU HU0402644A patent/HUP0402644A3/hu unknown
- 2002-12-12 PL PL02373072A patent/PL373072A1/xx not_active IP Right Cessation
- 2002-12-12 BR BR0215043-3A patent/BR0215043A/pt not_active Application Discontinuation
- 2002-12-12 SI SI200230865T patent/SI1458447T1/sl unknown
- 2002-12-12 CN CNB028249119A patent/CN100335060C/zh not_active Expired - Fee Related
- 2002-12-12 DK DK02793018.9T patent/DK1458447T3/da active
- 2002-12-12 RU RU2004121144/15A patent/RU2329050C2/ru not_active IP Right Cessation
- 2002-12-12 JP JP2003550795A patent/JP2005511723A/ja active Pending
- 2002-12-12 US US10/498,024 patent/US20050119338A1/en not_active Abandoned
- 2002-12-12 ES ES02793018T patent/ES2333206T3/es not_active Expired - Lifetime
- 2002-12-12 HR HR20040619A patent/HRP20040619A2/hr not_active Application Discontinuation
2004
- 2004-06-10 ZA ZA200404633A patent/ZA200404633B/en unknown
- 2004-06-14 MX MXPA04005755A patent/MXPA04005755A/es active IP Right Grant
- 2004-06-24 NO NO20042666A patent/NO20042666L/no not_active Application Discontinuation
2009
- 2009-12-09 CY CY20091101283T patent/CY1110604T1/el unknown

Also Published As

Publication number	Publication date
RU2004121144A (ru)	2005-04-20
TWI286476B (en)	2007-09-11
WO2003049746A2 (en)	2003-06-19
PT1458447E (pt)	2009-12-16
TW200409624A (en)	2004-06-16
EP1458447A2 (en)	2004-09-22
HUP0402644A3 (en)	2008-04-28
CA2469343A1 (en)	2003-06-19
CA2469343C (en)	2008-05-13
KR20040071182A (ko)	2004-08-11
ES2333206T3 (es)	2010-02-18
US20050119338A1 (en)	2005-06-02
ATE442189T1 (de)	2009-09-15
ZA200404633B (en)	2005-09-01
BR0215043A (pt)	2004-11-03
CN1604803A (zh)	2005-04-06
AR037797A1 (es)	2004-12-01
DK1458447T3 (da)	2010-01-18
AU2002358713A1 (en)	2003-06-23
PL373072A1 (en)	2005-08-08
IL162353A0 (en)	2005-11-20
JP2005511723A (ja)	2005-04-28
RU2329050C2 (ru)	2008-07-20
CN100335060C (zh)	2007-09-05
WO2003049746A3 (en)	2003-12-31
AU2002358713B2 (en)	2009-01-29
MXPA04005755A (es)	2004-09-10
KR100974921B1 (ko)	2010-08-09
HK1070008A1 (en)	2005-06-10
SI1458447T1 (sl)	2010-01-29
NZ533826A (en)	2006-04-28
HUP0402644A2 (en)	2007-02-28
EP1458447B1 (en)	2009-09-09
CY1110604T1 (el)	2015-04-29
HRP20040619A2 (en)	2005-08-31
DE60233677D1 (de)	2009-10-22

Legal Events

Date	Code	Title	Description
2012-01-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20042666L (no)	2004-09-09	Kombinasjon av cytokrom P450-avhengige proteaseinhibitorer
NO20041180L (no)	2004-03-19	Pyrrolopyrimidiner som midler for inbibering av cysteinprotaser
CY2015028I2 (el)	2016-07-27	Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
PL373399A1 (en)	2005-08-22	Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
DE60233399D1 (de)	2009-10-01	Erzerrung zweiter ordnung
PL375486A1 (en)	2005-11-28	Potent inhibitor of hcv serine protease
DE60234125D1 (de)	2009-12-03	E inhibitoren
CY2012007I2 (el)	2014-07-02	Πεπτιδομιμητικοι αναστολεις πρωτεασης
NO20034045D0 (no)	2003-09-12	Metallproteinase-inhibitorer
DE60230934D1 (de)	2009-03-05	Fab-i-inhibitoren
EP1499336A4 (en)	2005-06-01	PROTEASE INHIBITORS
ATE357432T1 (de)	2007-04-15	Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
NO20034032D0 (no)	2003-09-11	Metallproteinase-inhibitorer
FI20010558L (fi)	2002-09-20	Kappaleiden paikannus
DE60232067D1 (de)	2009-06-04	2-amino-benzoxazol-suphonamide als breitspektrum-hiv-protease-inhibitoren
NO20025786D0 (no)	2002-12-02	Protaseinhibitorer
DE60226715D1 (de)	2008-07-03	Monoamin-aufnahme-inhibitor
NO20025005D0 (no)	2002-10-17	Proteaseinhibitorer
EP1401453A4 (en)	2005-04-06	PROTEASE INHIBITORS
AU2002348465A1 (en)	2003-05-06	Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease
FI20012295A0 (fi)	2001-11-23	Hyvyysluku
NO20032328D0 (no)	2003-05-22	Proteaseinhibitorer
DE60124397D1 (de)	2006-12-21	Inhibitoren von serinproteasen
NO20013036D0 (no)	2001-06-19	HC-dekkgass
ATE270267T1 (de)	2004-07-15	Scyphostatin-analoga als smase-inhibitoren